Craneware (LON:CRW) Shares Climb 2.2% – Should You Buy?

Craneware plc (LON:CRW)’s stock price traded up 2.2% during trading on Tuesday. The company traded as high as GBX 1,056 and last traded at GBX 1,030. Approximately 862,850 shares were traded during mid-day trading, an increase of 31% from the average session volume of 657,188 shares. The stock had previously closed at GBX 1,008.

Analysts Set New Price Targets

Separately, Berenberg Bank lowered their target price on shares of Craneware from GBX 2,600 to GBX 1,600 and set a “buy” rating for the company in a research note on Monday, September 21st. Three equities research analysts have rated the stock with a Buy rating. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of GBX 1,673.33.

Craneware Price Performance

The company has a market capitalization of £364.48 million, a price-to-earnings ratio of 18.93 and a beta of 0.28. The company has a debt-to-equity ratio of 14.60, a quick ratio of 1.00 and a current ratio of 0.83. The business has a 50 day moving average price of GBX 1,129.63 and a 200-day moving average price of GBX 1,336.50.

Insider Buying and Selling

In other Craneware news, insider Craig Preston sold 14,656 shares of the stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average price of GBX 1,035, for a total transaction of £151,689.60. Also, insider Susan Nelson purchased 1,408 shares of the business’s stock in a transaction on Tuesday, September 22nd. The shares were acquired at an average price of GBX 1,054 per share, for a total transaction of £14,840.32. Insiders own 10.37% of the company’s stock.

Craneware Company Profile

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.